Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Autolus Therapeutics' Other Non-Current Assets fell 19.36% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 19.36%. This contributed to the annual value of $963000.0 for FY2024, which is 203.46% down from last year.
  • Autolus Therapeutics' Other Non-Current Assets amounted to $1.0 million in Q3 2025, which was down 19.36% from $5.3 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Other Non-Current Assets registered a high of $5.3 million during Q2 2025, and its lowest value of -$5000.0 during Q3 2022.
  • For the 5-year period, Autolus Therapeutics' Other Non-Current Assets averaged around $1.6 million, with its median value being $1.0 million (2024).
  • As far as peak fluctuations go, Autolus Therapeutics' Other Non-Current Assets tumbled by 10027.84% in 2022, and later skyrocketed by 1884000.0% in 2023.
  • Over the past 5 years, Autolus Therapeutics' Other Non-Current Assets (Quarter) stood at $2.4 million in 2021, then fell by 7.87% to $2.2 million in 2022, then plummeted by 54.83% to $983000.0 in 2023, then fell by 2.03% to $963000.0 in 2024, then increased by 7.06% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $5.3 million for Q2 2025, and $993000.0 during Q1 2025.